Clinical Trials Sponsored by CytoMed & Beike

Total 135 results

CytoMed & Beike

Unknown

Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis (hUC-MSC-SLE)

Lupus Nephritis

China
Beike Biotech India Pvt.ltd

Unknown

A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia

Diabetic Foot | Critical Limb Ischemia | Leg Ulcers

India
CytoMed Therapeutics Pte Ltd

Unknown

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Sarcoma | Nasopharyngeal Carcinoma | Gastric Cancer | Colorectal Cancer | Prostate Cancer | Triple Negative Breast Cancer

Malaysia
Shenzhen Beike Bio-Technology Co., Ltd.

Unknown

Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure

Premature Ovarian Failure，

China
Cytomedix

Terminated

AutoloGel Therapy to Usual and Customary Care in Pressure Ulcers

Pressure Ulcer

United States
Nycomed

Completed

Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)

Osteoporosis

Denmark
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD) (PANTHER)

Gastroesophageal Reflux Disease

Germany
Nycomed

Completed

Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders (PANDA)

Gastroesophageal Reflux Disease | Sleep Disorders | Non-Erosive Reflux Disease

Germany
Nycomed

Completed

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease (PARADE)

Gastroesophageal Reflux Disease

Germany
Nycomed

Withdrawn

RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)

Coronary Disease
Nycomed

Completed

ImproveR International (BI-001-IM)

Thrombin-specific Anticoagulant Bivalirudin During Percutaneous Coronary Intervention (PCI)

Denmark
Cytomedix

Terminated

Efficacy of AutoloGel Therapy to Usual and Customary Care in Wagner gd 1 and 2 Diabetic Foot Ulcers.

Diabetic Foot Ulcer

United States
Cytomedix

Terminated

Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers

Diabetic Foot Ulcers

United States
Cytomedix

Withdrawn

A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers

Impaired Wound Healing
Cytomedix

Terminated

A Cohort Trial Comparing AutoloGel Therapy to Usual and Customary Care in Venous Leg Ulcers

Venous Leg Ulcer

United States
Nycomed

Terminated

The Effect of PTH(1-84) or Alendronate on Reduction of Back Pain in Postmenopausal Women With an Osteoporosis Related Vertebral Fracture(s) (FP-005-IM)

Back Pain

Denmark
Nycomed

Completed

Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)

Colorectal Anastomosis

Germany, Netherlands, United Kingdom
Nycomed

Completed

Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil®

Hemorrhage

Germany
Nycomed

Completed

PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

Osteoporosis | Postmenopause

Germany
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease (BY1023/DE-004)

Gastroesophageal Reflux

Germany
Nycomed

Completed

TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM)

Intraoperative Complications | Pulmonary Diseases

Denmark
Nycomed

Completed

Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Cancer

Denmark
Nycomed

Completed

Non-interventional Trial About Treatment of Haemorrhages in Cholecystectomy With TachoSil (TC-027-DE)

Hemorrhage

Denmark
Nycomed

Completed

TachoSil Paediatric Liver Trial (TC-019-IN)

Liver Diseases

Denmark
Nycomed

Completed

Intranasal Fentanyl for the Treatment of Breakthrough Pain in Cancer Patients (FT-017-IM)

Pain | Cancer

Denmark
Nycomed

Completed

OSHES - Observational Study on Hemostasis in Surgery (TC-022-IT)

Blood Loss, Surgical | Hemostasis

Denmark
Cytomedix

Withdrawn

Effectiveness of Aurix Therapy in Venous Leg Ulcers

Venous Leg Ulcers

United States
Nycomed

Completed

Matrifen® for Therapy of Severe Chronic Pain® (Matrix LQ)

Severe Chronic Pain

Germany
Nycomed

Completed

TachoSil® Versus Standard Haemostatic Treatment of Haemorrhage in Cardiovascular Surgery (TC-023-IM)

Haemorrhage | Cardiovascular Surgery | Haemostasis

Denmark
Nycomed

Completed

Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS) (PULS)

Erosive Gastroesophageal Reflux Disease | Non-Erosive Reflux Disease

Germany
Nycomed

Completed

Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)

Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain.
Nycomed

Completed

STEP: Study of Imaging Techniques (ImaTx and DXA) in Postmenopausal Women With OstEoporosis Using Preotact (FP-008-ES)

Postmenopausal Women With Primary Osteoporosis

Denmark
Nycomed

Completed

Efficacy of Matrifen in Patients Older Than 18 Years With Severe, Chronic Pain (MATRIX II)

Severe, Chronic Pain

Germany
Nycomed

Completed

Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)

Symptomatic Diabetic Peripheral Polyneuropathy

Denmark
Nycomed

Completed

Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers

Healthy

Germany
Nycomed

Completed

Observational Cohort Study of TachoSil (TC-018-IN)

Blood Loss, Surgical

Denmark
Nycomed

Completed

Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM)

Common Cold
Nycomed

Completed

Comparison of Nasal Fentanyl and Oral Transmucosal Fentanyl (Actiq) in Cancer Breakthrough Pain (FT-019-IM)

Pain

Denmark
Nycomed

Completed

Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers

Type 2 Diabetes Mellitus

Germany
Nycomed

Completed

Assess Efficacy and Safety of TachoComb H vs. Standard Surgical Treatment (i.e. Suturing) in Patients Undergoing Prostatectomy (TC-017-AU)

Control of Local Bleeding in Patients Undergoing Prostatectomy.

Denmark
Durect
Nycomed

Completed

A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery

Postoperative Pain

New Zealand, Australia
CreoMed, Inc.

Suspended

Heavy Metal Urine Analysis in 20 Healthy Persons Taking Mineralox

Healthy

United States
Cytogen Corporation

Unknown

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer (CYT-500)

Metastatic Prostate Cancer

United States
Durect
Nycomed

Completed

An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder Surgery

Postoperative Pain

Austria, Germany, Latvia, Poland, Sweden
Durect
Nycomed

Completed

An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy

Postoperative Pain

France, Germany, Hungary, Latvia, Sweden, United Kingdom
Durect
Nycomed

Completed

A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair

Postoperative Pain | Hernia | Surgery

New Zealand, Australia
Cytogen Corporation

Unknown

Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer

Prostatic Neoplasms

United States
CytomX Therapeutics

Recruiting

First In Human Study of CX-2051 in Advanced Solid Tumors

Solid Tumor, Adult

United States
CytomX Therapeutics

Recruiting

A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors

Solid Tumors

United States
CytomX Therapeutics

Completed

Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer

Neoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 Negative

United States, Spain, Korea, Republic of

3

Subscribe